Nonmydriatic Fundus Cameras Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Nonmydriatic Fundus Cameras Market size was estimated at USD 204.9 million in 2026 and is projected to grow at a 5.61% CAGR from 2027 to 2036, attaining USD 353.67 million by 2036. The industry revenue for 2027 is calculated at USD 214.57 million.
Get more details on this report
Request Free Sample ReportNonmydriatic Fundus Cameras Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 39.64% share, driven by routine retinal imaging adoption, integrated diabetic retinopathy screening workflows, and strong access to advanced diagnostic equipment across clinical settings.
- Asia Pacific is growing at a 6.78% CAGR due to rising demand for high-volume, efficient eye screening and wider adoption of fast, non-dilated retinal imaging in resource-constrained care settings.
Segment Momentum
- Tabletop systems held a 53.55% market share in 2026 due to their routine use in structured clinical settings, where stable image capture, consistent workflows, and dependable retinal imaging support everyday diagnostic practice.
- Ophthalmic & optometrist offices are the fastest-growing end-use segment as retinal imaging becomes part of routine consultations, enabling earlier screening and more efficient in-office patient assessment.
Market Expansion Drivers
- Rising prevalence of diabetic retinopathy and glaucoma increasing demand for retinal screening technologies.
- Advancements in high-resolution ophthalmic imaging improving diagnostic accuracy and workflow efficiency.
- Expanding preventive eye care programs boosting adoption of rapid noninvasive retinal examinations.
Leading Market Participants
- Major players in the nonmydriatic fundus cameras market include Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Canon Medical Systems Corporation (Japan), NIDEK Co., Ltd. (Japan), Kowa Company, Ltd. (Japan), Optomed Plc (Finland), Haag-Streit AG (Switzerland), Optos plc (United Kingdom).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 204.9 million
- 2027 Estimated Market Size: USD 214.57 million.
- Projected Market Size: USD 353.67 million by 2036
- Growth Forecast: 5.61% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Tabletop (Type) | Hospitals (End-use)
- Emerging Opportunity Segment: Handheld (Type) | Ophthalmic & Optometrist Offices (End-use)
Market Growth Drivers and Industry Trends
Rising prevalence of diabetic retinopathy and glaucoma increasing demand for retinal screening technologies
The rising incidence of diabetic retinopathy and glaucoma will drive the nonmydriatic fundus cameras market growth by increasing the need for routine retinal examination and early detection of vision-threatening conditions. Growing diabetic and aging populations are contributing to a larger pool of patients requiring periodic monitoring of retinal health, while glaucoma often progresses without noticeable symptoms during its early stages. Nonmydriatic fundus cameras enable rapid capture of retinal images without pharmacological pupil dilation, making screening more convenient across ophthalmology clinics, diabetic care centers, and primary healthcare settings. Their ability to document retinal changes and support repeat examinations also facilitates ongoing disease monitoring, particularly for patients requiring regular assessment of disease progression.
Advancements in high-resolution ophthalmic imaging improving diagnostic accuracy and workflow efficiency
Advancements in high-resolution ophthalmic imaging are strengthening the nonmydriatic fundus cameras market by enabling clearer visualization of subtle retinal abnormalities and improving the consistency of image-based examinations. Enhanced image resolution, improved sensors, automated image capture, and better image-processing capabilities can assist clinicians in identifying lesions, vascular changes, hemorrhages, and other retinal abnormalities with greater clarity. Integration with digital ophthalmology workflows further allows images to be stored, reviewed, shared, and incorporated into patient records, reducing manual handling during examinations. These capabilities are particularly valuable in busy eye-care environments where efficient imaging and reliable documentation are important for screening and follow-up assessments.
Expanding preventive eye care programs boosting adoption of rapid noninvasive retinal examinations
The expansion of preventive eye care initiatives will propel nonmydriatic fundus cameras market demand as healthcare providers increasingly emphasize early identification of retinal disorders before substantial vision loss occurs. Community screening campaigns, diabetes management programs, occupational health initiatives, and primary-care-based eye assessments can benefit from examination methods that are rapid, noninvasive, and comparatively simple to deploy. Because retinal imaging can be performed without routine dilation, healthcare personnel can conduct examinations with less disruption to patients and clinical workflows. Wider incorporation of retinal screening into preventive care pathways can therefore increase the use of compact and digitally connected imaging systems across settings beyond conventional ophthalmology practices.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of diabetic retinopathy and glaucoma increasing demand for retinal screening technologies | 2.00% | High | North America, Asia Pacific | High | Near Term |
| Advancements in high-resolution ophthalmic imaging improving diagnostic accuracy and workflow efficiency | 1.70% | Moderate | Europe, North America | Medium | Mid Term |
| Expanding preventive eye care programs boosting adoption of rapid noninvasive retinal examinations | 1.40% | High | Asia Pacific, Latin America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the nonmydriatic fundus cameras market, accounting for 39.64% in 2026. The region’s strong position is supported by advanced ophthalmic care infrastructure, growing demand for efficient retinal screening, and increasing adoption of digital diagnostic technologies. Greater emphasis on early detection of diabetic eye disease and other retinal disorders, along with the integration of imaging systems into specialized and primary care settings, is encouraging broader use of nonmydriatic cameras.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is poised for the fastest growth as healthcare infrastructure expands and access to ophthalmic diagnostics improves across both developed and emerging markets. Rising awareness of preventable vision loss, growing screening needs associated with chronic diseases, and increasing investment in digital healthcare are creating favorable conditions for retinal imaging adoption. Portable and user-friendly camera systems are also helping extend screening capabilities to community and outpatient settings where conventional ophthalmic equipment may be less accessible.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Imaging PrecisionGermany emphasizes high-accuracy nonmydriatic fundus cameras that integrate with ophthalmology and hospital imaging systems. Medical facilities in Germany continue investing in dependable diagnostic equipment that enhances workflow efficiency while supporting standardized eye disease screening.
France 🇫🇷
Community Screening SupportFrance promotes nonmydriatic fundus cameras for accessible retinal screening across hospitals and community healthcare facilities. Medical providers in France prioritize user-friendly imaging systems that improve diagnostic consistency while supporting preventive ophthalmic care programs.
Italy 🇮🇹
Outpatient Imaging ExpansionItaly emphasizes practical nonmydriatic fundus camera deployment in ophthalmology clinics and outpatient diagnostic centers. Healthcare providers in Italy continue adopting versatile imaging systems that simplify retinal examinations while improving clinical workflow efficiency.
Japan 🇯🇵
Preventive Vision CareJapan focuses on nonmydriatic fundus cameras for preventive eye examinations and routine health screening. Healthcare institutions in Japan continue expanding compact, high-resolution imaging solutions that improve diagnostic efficiency while addressing the needs of an aging population.
South Korea 🇰🇷
Smart Imaging IntegrationSouth Korea supports nonmydriatic fundus camera adoption through digital healthcare initiatives and advanced ophthalmic diagnostics. Providers in South Korea increasingly integrate imaging platforms with AI-assisted analysis to streamline retinal assessments and improve patient management.
United States 🇺🇸
Digital Eye DiagnosticsThe U.S. nonmydriatic fundus cameras market prioritizes efficient retinal imaging across hospitals, clinics, and primary care settings. Healthcare providers in the U.S. increasingly adopt AI-compatible imaging systems that improve screening workflows and support earlier detection of retinal diseases.
Segment Leadership and Growth Trends
Nonmydriatic Fundus Cameras Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Tabletop (Largest Segment) vs Handheld (Fastest-Growing Segment)
Tabletop systems dominated the nonmydriatic fundus cameras market, accounting for a 53.55% share in 2026. Their leading position is supported by their established use in ophthalmic facilities where imaging systems are integrated into routine examination workflows. Tabletop cameras generally provide stable positioning, consistent image acquisition, and features suited to detailed retinal examinations, making them valuable for clinical environments that conduct regular eye screening and diagnostic procedures. Their compatibility with established ophthalmic infrastructure and suitability for repeated examinations further supports adoption among healthcare providers. As the need for retinal imaging increases for the assessment and monitoring of ocular and systemic conditions, tabletop systems continue to serve as a dependable imaging platform.
Handheld fundus cameras are expected to register the fastest growth as eye-care providers increasingly seek portable imaging solutions that can be used across a broader range of patient-care environments. Their compact design allows retinal imaging to be performed outside conventional ophthalmic examination rooms, supporting screening in primary care, outreach programs, bedside settings, and other locations where mobility is important. Handheld systems can also improve accessibility for patients who may have difficulty visiting specialized ophthalmology facilities. The increasing emphasis on decentralized eye screening and early identification of retinal abnormalities is creating favorable conditions for wider adoption of portable fundus imaging technologies.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ophthalmic & Optometrist Offices (Fastest-Growing Segment)
Hospitals accounted for the largest share of the nonmydriatic fundus cameras market, representing 47.49% in 2026. Hospitals have a strong need for retinal imaging equipment because ophthalmic evaluation can form part of both specialized eye-care services and broader diagnostic workflows. Fundus cameras are useful for documenting retinal conditions, monitoring disease progression, and supporting clinical assessments, particularly in settings with access to multidisciplinary healthcare teams. The presence of established diagnostic infrastructure and the ability to integrate imaging into comprehensive patient-care pathways further support hospital adoption. Growing attention to early detection of retinal abnormalities is reinforcing the role of fundus imaging within hospital-based care.
Ophthalmic & optometrist offices are positioned as the fastest-growing end-use segment as eye-care services increasingly emphasize accessible and efficient diagnostic screening. Office-based practitioners can use nonmydriatic fundus cameras to capture retinal images during routine examinations without relying on more specialized hospital infrastructure. The technology can support earlier identification of abnormalities and improve documentation for follow-up assessments, making it valuable in outpatient eye-care workflows. Increasing demand for convenient eye examinations and the broader integration of digital imaging into routine optometric and ophthalmic practice are supporting stronger adoption across these offices.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Tabletop, Handheld | Tabletop | Handheld |
| End-use | Hospitals, Ophthalmology Clinics, Ophthalmic & Optometrist Offices | Hospitals | Ophthalmic & Optometrist Offices |
Competitive Landscape and Market Positioning
Prominent players in the nonmydriatic fundus cameras market:
1. Carl Zeiss Meditec AG (Germany)
2. Topcon Corporation (Japan)
3. Canon Medical Systems Corporation (Japan)
4. NIDEK Co. Ltd. (Japan)
5. Kowa Company Ltd. (Japan)
6. Optomed Plc (Finland)
7. Haag-Streit AG (Switzerland)
8. Optos plc (United Kingdom)
The nonmydriatic fundus cameras market is progressing through enhanced imaging clarity and diagnostic efficiency innovations. Continuous R&D is enabling more accurate and patient-friendly ophthalmic solutions. The market is also witnessing frequent upgrades aligned with clinical imaging needs.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Carl Zeiss Meditec AG (Germany) | |||||||
| Topcon Corporation (Japan) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| NIDEK Co. Ltd. (Japan) | |||||||
| Kowa Company Ltd. (Japan) | |||||||
| Optomed Plc (Finland) | |||||||
| Haag-Streit AG (Switzerland) | |||||||
| Optos plc (United Kingdom). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Topcon Healthcare, Inc. | Jul-24 | Topcon Healthcare appointed Lance Patton as Chief Commercial Officer to lead its transition toward a direct sales and service model. The role focuses on commercial restructuring, integration of AI-enabled disease detection solutions, and development of customized ophthalmic imaging offerings to strengthen market positioning in diagnostic eye care solutions. |
| Optomed | May-24 | Optomed launched the Aurora AEYE handheld fundus camera integrated with artificial intelligence capabilities for rapid detection of mild diabetic retinopathy. The device enables point-of-care retinal screening in primary care settings, supporting early disease identification and expanding access to nonmydriatic ophthalmic imaging in decentralized healthcare environments. |
| NIDEK CO., LTD.; Orbis International | Jan-24 | NIDEK CO., LTD. and Orbis International partnered to enhance AI-based eye screening programs in Vietnam through the deployment of donated fundus cameras. The collaboration supports diabetic retinopathy screening initiatives and strengthens the integration of artificial intelligence into ophthalmic diagnostics across emerging healthcare markets. |
| Carl Zeiss Meditec AG | Dec-23 | Carl Zeiss Meditec AG acquired the Dutch Ophthalmic Research Center to expand its ophthalmic portfolio and digitally enabled workflow solutions. The acquisition strengthens its position in advanced eye care technologies by broadening its diagnostic imaging capabilities and enhancing its integrated ophthalmology solutions across multiple eye disease applications. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Nonmydriatic Fundus Cameras Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| AI Integration Level | Non-AI Imaging, AI-Assisted Screening, AI-Based Automated Screening |
| Connectivity Architecture | Standalone, Network-Connected, Cloud-Connected |
| Purchasing Model | Capital Equipment Purchase, Leasing, Managed Equipment & Service Contracts |
Nonmydriatic Fundus Cameras Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| AI-Enabled Retinal Diagnostics Landscape |
|
| Teleophthalmology Opportunity Mapping |
|
| Ophthalmic Screening Adoption Analysis |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the nonmydriatic fundus cameras market generate?
What is the forecasted size of the nonmydriatic fundus cameras industry?
How is the rising burden of diabetic retinopathy and glaucoma reshaping retinal screening adoption across frontline care settings?
Why are preventive eye care programs becoming a key demand driver for nonmydriatic fundus camera deployment?
Why do tabletop nonmydriatic fundus cameras lead the market?
Which end-use segment is growing the fastest in the nonmydriatic fundus cameras market?
Why is North America leading the nonmydriatic fundus cameras market?
How is Asia Pacific driving fastest growth in this market?
What are the prominent companies operating in the nonmydriatic fundus cameras landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization